Skip to main content
Premium Trial:

Request an Annual Quote

OriGene, ProteinOne Pen Distribution/Use Agreement

NEW YORK, Aug. 11 (GenomeWeb) - OriGene, a maker of cDNA clones, will  distribute and use a protein array made by ProteinOne, the companies said yesterday.


OriGene also intends to use ProteinOne's custom protein services, which the company said will complement its True Clone collection of full-length cDNA clones.

At the same time, ProteinOne will use OriGene's clones for protein-expression research, and will promote OriGene's clone technology.


Financial details of the deal were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.